USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: Neogen Corporation
Address: 620 Lesher Place
Lansing, MI 48912
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: (517) 372-9200

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $373,362.00 7
SBIR Phase II $744,239.00 3

Award List:

THE LONG TERM OBJECTIVE IS TO DEVELOP COMMERCIAL APPLICATIONS OF NEWER BIOTECHNOLOGICAL METHODS FOR VACCINE DEVELOPMENT TO ELIMINATE PROBLEMS RESULTING FROM DISEASES CAUSED BY HERPESVIRUS.

Award Year / Program / Phase: 1984 / SBIR / Phase I
Agency: HHS
Principal Investigator: Yathirajulu naidu , SENIOR SCIENTIST
Award Amount: $38,554.00
Abstract:
The long term objective is to develop commercial applications of newer biotechnological methods for vaccine development to eliminate problems resulting from diseases caused by herpesvirus. it is proposed to use the "marek's disease system" as an animal, virological and molecular model for research… More

PRODUCTION OF POLYCLONAL AND MONOCLONAL ANTIBODIES FOR DETECTION OF SULFONAMIDES

Award Year / Program / Phase: 1988 / SBIR / Phase I
Agency: NSF
Principal Investigator: Dr deborah e dixon-hollan
Award Amount: $41,000.00
Abstract:
Neogen is committed to development of diagnostics which willimprove the health of both plants and animals. using information gathered from production of antibodies which recognize various mycotoxins, similar procedures would be used to produce polyclonal antiserum in rabbits and monoclonal… More

PRODUCTION AND CHARACTERIZATION OF POLYCLONAL ANTIBODIES AGAINST MALIC ENZYME AND POST INITIATION PROTEIN NUMBER 5

Award Year / Program / Phase: 1990 / SBIR / Phase I
Agency: NSF
Principal Investigator: Dr Brinton M Miller , Vice President
Award Amount: $49,735.00

PRODUCTION AND CHARACTERIZATION OF POLYCLONAL ANTIBODIES AGAINST MALIC ENZYME AND POST INITIATION PROTEIN NUMBER 5

Award Year / Program / Phase: 1992 / SBIR / Phase II
Agency: NSF
Principal Investigator: Dr Brinton M Miller , Vice President
Award Amount: $248,239.00
Abstract:
The goal of neogen corporation is to develop diagnostics which improve plant and animal health. neogen's research and development of immunoassays for undesirable residues (e.g. mycotoxins, sulfamethazine) utilizes the same technology that may be applied to detecting desirable factors (e.g. ripening… More

A TIME-TEMPERATURE HISTORY SENSOR

Award Year / Program / Phase: 1992 / SBIR / Phase I
Agency: USDA
Principal Investigator: Dr B A Torgerson
Award Amount: $49,800.00

A TIME-TEMPERATURE HISTORY SENSOR

Award Year / Program / Phase: 1993 / SBIR / Phase II
Agency: USDA
Principal Investigator: Dr B A Torgerson
Award Amount: $200,000.00
Abstract:
A device for monitoring time temperature history is proposed. the sensing component of the device, unlike other competing sensors, does not require electronic data recovery or have a narrow temperature range of operation. the sensor functions by use of a proprietary chemical reaction to store data… More

MONOCLONAL ANTIBODIES FOR AN ELISA FOR THE ETHYLENE-RELATED PROTEIN PAPER-1

Award Year / Program / Phase: 1993 / SBIR / Phase I
Agency: USDA
Principal Investigator: Dr Deborah E Dixon-hollan
Award Amount: $49,600.00
Abstract:
Neogen corporation has developed numerous immunoassays currently in wide commercial practice to detect and quantify toxic residues (e.g. mycotoxins, sulfonamides). technology is currently being developed for detecting and quantifying the developmentally regulated enzyme… More

Development of a Rapid Test for Detection of Salmonella Enteritidis

Award Year / Program / Phase: 1999 / SBIR / Phase I
Agency: USDA
Principal Investigator: Joseph M. Madden
Award Amount: $64,985.00

Development of a Vaccine for the Prevention of Clostridium Botulinum Type C in Equine and Bovine Species

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: USDA
Principal Investigator: Joseph M. Madden
Award Amount: $79,688.00
Abstract:
Horses and cattle are susceptible to the neurotoxin produced by Clostridium botulinum Type C, one of the types of botulism. The purpose of this project is to develop a toxoid to protect horses and cattle (particularly dairy cattle) against this disease.

Determination of the Safety and Efficacy of a Toxoid Developed for the Prevention of Type C Botulism in Horses

Award Year / Program / Phase: 2005 / SBIR / Phase II
Agency: USDA
Principal Investigator: Joseph M. Madden, VP, Scientific Affairs
Award Amount: $296,000.00
Abstract:
Type C botulism is becoming more frequent in horses in the US due to changes modernization has made in harvesting of silage fed to farm animals. This project will determine the safety of and effectiveness of an experimental toxoid for the prevention of this illness in horses.